Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 9 de 9
Filter
Add more filters










Database
Language
Publication year range
1.
Int J Mol Sci ; 24(2)2023 Jan 13.
Article in English | MEDLINE | ID: mdl-36675148

ABSTRACT

Since 2000, some thirteen quinolones and fluoroquinolones have been developed and have come to market. The quinolones, one of the most successful classes of antibacterial drugs, stabilize DNA cleavage complexes with DNA gyrase and topoisomerase IV (topo IV), the two bacterial type IIA topoisomerases. The dual targeting of gyrase and topo IV helps decrease the likelihood of resistance developing. Here, we report on a 2.8 Å X-ray crystal structure, which shows that zoliflodacin, a spiropyrimidinetrione antibiotic, binds in the same DNA cleavage site(s) as quinolones, sterically blocking DNA religation. The structure shows that zoliflodacin interacts with highly conserved residues on GyrB (and does not use the quinolone water-metal ion bridge to GyrA), suggesting it may be more difficult for bacteria to develop target mediated resistance. We show that zoliflodacin has an MIC of 4 µg/mL against Acinetobacter baumannii (A. baumannii), an improvement of four-fold over its progenitor QPT-1. The current phase III clinical trial of zoliflodacin for gonorrhea is due to be read out in 2023. Zoliflodacin, together with the unrelated novel bacterial topoisomerase inhibitor gepotidacin, is likely to become the first entirely novel chemical entities approved against Gram-negative bacteria in the 21st century. Zoliflodacin may also become the progenitor of a new safer class of antibacterial drugs against other problematic Gram-negative bacteria.


Subject(s)
Quinolones , Staphylococcal Infections , Humans , DNA Gyrase/metabolism , Staphylococcus aureus/metabolism , DNA Topoisomerase IV/genetics , DNA Cleavage , Anti-Bacterial Agents/pharmacology , Anti-Bacterial Agents/chemistry , Quinolones/pharmacology , Fluoroquinolones , Topoisomerase II Inhibitors/pharmacology , Bacteria/metabolism , Microbial Sensitivity Tests , DNA Topoisomerases, Type II/metabolism
2.
Nat Commun ; 12(1): 150, 2021 01 08.
Article in English | MEDLINE | ID: mdl-33420011

ABSTRACT

Novel bacterial type II topoisomerase inhibitors (NBTIs) stabilize single-strand DNA cleavage breaks by DNA gyrase but their exact mechanism of action has remained hypothetical until now. We have designed a small library of NBTIs with an improved DNA gyrase-binding moiety resulting in low nanomolar inhibition and very potent antibacterial activity. They stabilize single-stranded cleavage complexes and, importantly, we have obtained the crystal structure where an NBTI binds gyrase-DNA in a single conformation lacking apparent static disorder. This directly proves the previously postulated NBTI mechanism of action and shows that they stabilize single-strand cleavage through asymmetric intercalation with a shift of the scissile phosphate. This crystal stucture shows that the chlorine forms a halogen bond with the backbone carbonyls of the two symmetry-related Ala68 residues. To the best of our knowledge, such a so-called symmetrical bifurcated halogen bond has not been identified in a biological system until now.


Subject(s)
Anti-Bacterial Agents/pharmacology , Chlorine/metabolism , DNA Gyrase/metabolism , Topoisomerase II Inhibitors/pharmacology , Alanine/chemistry , Alanine/metabolism , Anti-Bacterial Agents/chemistry , Crystallography, X-Ray , DNA Gyrase/chemistry , DNA Topoisomerases, Type II , DNA, Single-Stranded/metabolism , Drug Design , ERG1 Potassium Channel/metabolism , Escherichia coli/drug effects , Escherichia coli/enzymology , Hep G2 Cells , Human Umbilical Vein Endothelial Cells , Humans , Inhibitory Concentration 50 , Microbial Sensitivity Tests , Molecular Docking Simulation , Poly-ADP-Ribose Binding Proteins/antagonists & inhibitors , Quinolines/chemistry , Quinolines/pharmacology , Staphylococcus aureus/drug effects , Staphylococcus aureus/enzymology , Topoisomerase II Inhibitors/chemistry
3.
Biotechniques ; 69(5): 356-362, 2020 11.
Article in English | MEDLINE | ID: mdl-33000631

ABSTRACT

Decatenation is a crucial in vivo reaction of DNA topoisomerases in DNA replication and is frequently used in in vitro drug screening. Usually this reaction is monitored using kinetoplast DNA as a substrate, although this assay has several limitations. Here we have engineered a substrate for Tn3 resolvase that generates a singly-linked catenane that can readily be purified from the DNA substrate after restriction enzyme digestion and centrifugation. We show that this catenated substrate can be used with high sensitivity in topoisomerase assays and drug-inhibition assays.


Subject(s)
DNA Topoisomerases/metabolism , DNA, Catenated/metabolism , Enzyme Assays/methods , Base Sequence , Recombination, Genetic/genetics , Substrate Specificity , Transposon Resolvases/metabolism
4.
BMC Res Notes ; 11(1): 37, 2018 Jan 16.
Article in English | MEDLINE | ID: mdl-29338757

ABSTRACT

OBJECTIVE: Agarose gel electrophoresis has been the mainstay technique for the analysis of DNA samples of moderate size. In addition to separating linear DNA molecules, it can also resolve different topological forms of plasmid DNAs, an application useful for the analysis of the reactions of DNA topoisomerases. However, gel electrophoresis is an intrinsically low-throughput technique and suffers from other potential disadvantages. We describe the application of the QIAxcel Advanced System, a high-throughput capillary electrophoresis system, to separate DNA topoisomers, and compare this technique with gel electrophoresis. RESULTS: We prepared a range of topoisomers of plasmids pBR322 and pUC19, and a 339 bp DNA minicircle, and compared their separation by gel electrophoresis and the QIAxcel System. We found superior resolution with the QIAxcel System, and that quantitative analysis of topoisomer distributions was straightforward. We show that the QIAxcel system has advantages in terms of speed, resolution and cost, and can be applied to DNA circles of various sizes. It can readily be adapted for use in compound screening against topoisomerase targets.


Subject(s)
DNA, Superhelical/analysis , DNA/analysis , Electrophoresis, Agar Gel/methods , Electrophoresis, Capillary/methods , DNA/genetics , DNA Gyrase/metabolism , DNA Topoisomerases/metabolism , DNA, Superhelical/genetics , DNA, Superhelical/metabolism , Plasmids/genetics , Reproducibility of Results
5.
Methods Mol Biol ; 815: 229-39, 2012.
Article in English | MEDLINE | ID: mdl-22130995

ABSTRACT

We have developed a rapid, high-throughput assay for measuring the catalytic activity (DNA supercoiling or relaxation) of DNA topoisomerases. The assay utilizes intermolecular triplex formation between an immobilized triplex-forming oligo (TFO) and a triplex-forming region inserted into the plasmid substrate (pNO1), and capitalizes on the observation that supercoiled DNA forms triplexes more readily than relaxed DNA. Thus, supercoiled DNA is preferentially retained by the TFO under triplex-forming conditions while relaxed DNA can be washed away. Due to its high speed of sample analysis and reduced sample handling over conventional gel-based techniques, this assay can be used to screen chemical libraries for novel inhibitors of topoisomerases.


Subject(s)
DNA Gyrase/chemistry , Enzyme Assays/methods , Escherichia coli Proteins/chemistry , High-Throughput Screening Assays , DNA/chemistry , DNA/isolation & purification , DNA, Superhelical/chemistry , DNA, Superhelical/isolation & purification , Escherichia coli Proteins/antagonists & inhibitors , Humans , Nucleic Acid Conformation , Plasmids/chemistry , Plasmids/isolation & purification , Small Molecule Libraries , Topoisomerase II Inhibitors , Topoisomerase Inhibitors/chemistry
6.
Methods Mol Biol ; 613: 257-66, 2010.
Article in English | MEDLINE | ID: mdl-19997889

ABSTRACT

We have developed a rapid, high-throughput assay for measuring the catalytic activity (DNA supercoiling or relaxation) of topoisomerase enzymes that is also capable of monitoring the activity of other enzymes that alter the topology of DNA. The assay utilises intermolecular triplex formation to resolve supercoiled and relaxed forms of DNA, the principle being the greater efficiency of a negatively supercoiled plasmid to form an intermolecular triplex with an immobilised oligonucleotide than the relaxed form. The assay provides a number of advantages over the standard gel-based methods, including greater speed of analysis, reduced sample handling, better quantitation and improved reliability and accuracy of output data. The assay is performed in microtitre plates and can be adapted to high-throughput screening of libraries of potential inhibitors of topoisomerases including bacterial DNA gyrase.


Subject(s)
DNA Topoisomerases, Type I/metabolism , DNA/metabolism , Enzyme Assays/methods , Animals , Base Sequence , Cattle , DNA/genetics , DNA Gyrase/metabolism , DNA, Superhelical/metabolism , Enzyme Inhibitors/pharmacology , Escherichia coli/enzymology , High-Throughput Screening Assays , Humans , Inhibitory Concentration 50 , Oligodeoxyribonucleotides/chemistry , Oligodeoxyribonucleotides/genetics , Oligodeoxyribonucleotides/metabolism , Topoisomerase II Inhibitors
7.
Appl Environ Microbiol ; 73(13): 4294-9, 2007 Jul.
Article in English | MEDLINE | ID: mdl-17468267

ABSTRACT

A novel species of Acidimicrobium appeared to be the predominant ferrous iron oxidizer in a mixed culture that effected the continuous, efficient extraction of nickel from a mineral concentrate at 49 degrees C, but it was not isolated in pure culture. It outcompeted Acidimicrobium ferrooxidans, which was expected to have a major role in iron oxidation in reactors gassed with air, and was outnumbered at 49 degrees C only by the sulfur-oxidizing Acidithiobacillus caldus. Sulfobacillus species were expected to compete with Acidimicrobium species when culture aeration was enriched with carbon dioxide, but they were a minor component of the populations with and without this enrichment. Sulfobacillus thermosulfidooxidans replaced the Acidimicrobium species and Acidithiobacillus caldus when the temperature was increased to 55 degrees C.


Subject(s)
Actinobacteria/isolation & purification , Actinobacteria/metabolism , Actinobacteria/classification , Actinobacteria/genetics , Base Sequence , Bioreactors/microbiology , DNA Probes/genetics , DNA, Bacterial/genetics , Hot Temperature , Hydrogen-Ion Concentration , In Situ Hybridization, Fluorescence , Minerals/metabolism , Oxidation-Reduction , RNA, Bacterial/genetics , RNA, Ribosomal, 16S/genetics , Species Specificity , Sulfides/metabolism
8.
Nucleic Acids Res ; 34(15): e104, 2006.
Article in English | MEDLINE | ID: mdl-16936317

ABSTRACT

We have developed high-throughput microtitre plate-based assays for DNA gyrase and other DNA topoisomerases. These assays exploit the fact that negatively supercoiled plasmids form intermolecular triplexes more efficiently than when they are relaxed. Two assays are presented, one using capture of a plasmid containing a single triplex-forming sequence by an oligonucleotide tethered to the surface of a microtitre plate and subsequent detection by staining with a DNA-specific fluorescent dye. The other uses capture of a plasmid containing two triplex-forming sequences by an oligonucleotide tethered to the surface of a microtitre plate and subsequent detection by a second oligonucleotide that is radiolabelled. The assays are shown to be appropriate for assaying DNA supercoiling by Escherichia coli DNA gyrase and DNA relaxation by eukaryotic topoisomerases I and II, and E.coli topoisomerase IV. The assays are readily adaptable to other enzymes that change DNA supercoiling (e.g. restriction enzymes) and are suitable for use in a high-throughput format.


Subject(s)
Clinical Enzyme Tests/methods , DNA Gyrase/metabolism , DNA Topoisomerase IV/metabolism , DNA Gyrase/genetics , DNA Topoisomerase IV/genetics , DNA, Bacterial/metabolism , Escherichia coli/enzymology , Plasmids/genetics
9.
Appl Environ Microbiol ; 68(11): 5265-73, 2002 Nov.
Article in English | MEDLINE | ID: mdl-12406713

ABSTRACT

Soluble methane monooxygenase (sMMO) of Methylosinus trichosporium OB3b is a three-component oxygenase that catalyses the O(2)- and NAD(P)H-dependent oxygenation of methane and numerous other substrates. Despite substantial interest in the use of genetic techniques to study the mechanism of sMMO and manipulate its substrate specificity, directed mutagenesis of active-site residues was previously impossible because no suitable heterologous expression system had been found for expression in a highly active form of the hydroxylase component, which is an (alphabetagamma)(2) complex containing the binuclear iron active site. A homologous expression system that enabled the expression of recombinant wild-type sMMO in a derivative of M. trichosporium OB3b from which the chromosomal copy of the sMMO-encoding operon had been partially deleted was previously reported. Here we report substantial development of this method to produce a system for the facile construction and expression of mutants of the hydroxylase component of sMMO. This new system has been used to investigate the functions of Cys 151 and Thr 213 of the alpha subunit, which are the only nonligating protonated side chains in the hydrophobic active site. Both residues were found to be critical for the stability and/or activity of sMMO, but neither was essential for oxygenation reactions. The T213S mutant was purified to >98% homogeneity. It had the same iron content as the wild type and had 72% wild-type activity toward toluene but only 17% wild-type activity toward propene; thus, its substrate profile was significantly altered. With these results, we have demonstrated proof of the principle for protein engineering of this uniquely versatile enzyme.


Subject(s)
Mixed Function Oxygenases/genetics , Oxygenases/genetics , Amino Acid Substitution , Cysteine/genetics , Gene Expression , Genetic Vectors/genetics , Mixed Function Oxygenases/metabolism , Mutagenesis, Site-Directed , Oxygenases/metabolism , Protein Engineering , Protein Subunits , Serine/genetics , Solubility , Threonine/genetics
SELECTION OF CITATIONS
SEARCH DETAIL
...